Global Insulin Delivery Device Market to Reach $9 Billion by 2022 - Technological Advancements in the Delivery Device are Driving Growth - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Insulin Delivery Device Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering.

The global insulin delivery device market accounted for revenues of $9.9 billion in 2015, and it is expected to grow at a CAGR of 6.6% during 2016-2022.

Diabetes is a chronic disease caused due to insufficient production or inappropriate use of insulin in the body. Proper intervention is needed for diabetes, so as to reduce complications, such as damage of kidney, eyes, heart and feet, and death. Insulin in delivered with the help of various delivery devices such as insulin pumps, pen injectors, insulin syringe and jet injectors. Insulin syringes are most commonly used delivery system for self-medication. However, insulin syringe not being a convenient option resulted in development of other devices for the treatment of diabetes.

The global insulin delivery device market is growing at a significant rate, due to growing geriatric population, increasing prevalence of diabetes and increasing prevalence of obesity. In addition, the technological advancement in the delivery device and increasing awareness of diabetic care are also driving the growth of the global market. The increasing awareness of diabetes across the globe through campaigns, conferences and activities is creating awareness about the long term effects and complications of diabetes and encourages people to enter regular diabetes checkups. The restraints associated with the growth of the global insulin delivery device market include hazards and risks associated with delivery device and high analogue cost.

Companies Mentioned:

  • Medtronic Plc
  • Insulet Corporation
  • Abbott Laboratories
  • Novo Nordisk A/S
  • Eli Lilly And Company
  • Sanofi S.A.
  • Becton, Dickinson And Company
  • B. Braun Melsungen AG
  • Animas Corporation
  • Ypsomed Holding AG
  • F. Hoffmann-La Roche Ltd

Key Topics Covered:

1. Research Scope And Methodology

2.Executive Summary

3.Market Outlook

4.Global Insulin Delivery Device Market Size And Forecast (2012-2022)

5.Global Insulin Delivery Device Market, By Type

6.Global Insulin Delivery Device Market, By Geography

7.Competitive Analysis

8.Company Profiles And Strategic Developments

For more information about this report visit http://www.researchandmarkets.com/research/93f8zz/global_insulin

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diabetes Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diabetes Devices